Skip to main content
Equibles
LMMY logo

LMMY · Exousia Bio, Inc. · Metrics

Track LMMY — free

Use LMMY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LMMY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.01 At close · Nov 11
Rebalance outlook locked
Going-concern doubt — flagged Jun 16, 2026

Substantial doubt about the company's ability to continue as a going concern.

“The Company has not yet established an ongoing source of revenue sufficient to cover its operating costs and allow it to continue as a going concern. The Company has accumulated deficit from inception (January 31, 2022) to February 28, 2026, of $288,623. These factors among others raise substantial doubt about the ability of the company to continue as a going concern for a reasonable period of time.”
View the 10-Q filed Jun 16, 2026
Market Cap
$635,250
Shares
52.50M
Volume · Nov 11 14.18K Avg daily vol (3M) 84.51K

LMMY metrics

42 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.01
Market cap
$635,250

Price action

23 metrics
Price change (1W)
-10.4%
Price change (30D)
-30.9%
Price change (3M)
-97.0%
Price change (6M)
-97.4%
Price change (YTD)
-96.1%
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
$0.80
52-week low
$0.01
Change from 52-week high
-98.5%
Change from 52-week low
+0.0%
Annualized volatility
521.6%
Annualized volatility (3M)
—
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
—
RSI (14D)
35.8
Price vs SMA 50
-93.6%
Price vs SMA 200
-99.4%
Avg volume (3M)
84,266
Relative volume
0.1
Average dollar volume
$1,861

Company

3 metrics
Sector
Consumer Defensive
Industry
Education & Training Services
Shares outstanding
52.50M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
0.0
reciprocal yield 3,106.6%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
8.2
reciprocal yield 12.2%
Earnings yield
-11.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
−$69,359
Operating profit (TTM)
−$55,079
Net income (TTM)
−$80,161
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.31

Growth

11 metrics
Revenue growth YoY
-67.4%
Year over year
Net income growth YoY
-130.9%
Revenue (TTM)
$0
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+115.6%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-0.4%
Return on assets
-0.4%
Debt / equity
—
Current ratio
0.0
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$0
Latest balance sheet
Cash & equivalents
$0
Total assets
$22.05M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$85,560
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1939937 CUSIP 50172J105 Visit website Investor relations